News & Updates

Show Multimedia Only

Apixaban tied to lower VTE risk in ambulatory cancer patients

13 Aug 2020 by

Treatment with apixaban led to a significantly reduced risk of venous thromboembolism (VTE) among ambulatory cancer patients who were undergoing chemotherapy, according to two post hoc analyses of the AVERT* trial presented at the ISTH 2020 Meeting.

Apixaban tied to lower VTE risk in ambulatory cancer patients

13 Aug 2020

Predictors of psychological resilience in NSCLC patients after surgery

12 Aug 2020

Self-efficacy predicts psychological resilience among nonsmall cell lung cancer patients (NSCLC) who had undergone thoracic surgery, a new study finds.

Predictors of psychological resilience in NSCLC patients after surgery

12 Aug 2020

A new tool can predict Asian women's breast cancer risk and help them decide on a screening programme most suited for them.

10 Aug 2020 by

A multinational study involving participants from 10 countries has resulted in the creation of a risk scoring tool to stratify Asian women’s breast cancer risk.

A new tool can predict Asian women's breast cancer risk and help them decide on a screening programme most suited for them.

10 Aug 2020

News & Updates

Filter by Specialty:

Specialty:

Apixaban tied to lower VTE risk in ambulatory cancer patients

Apixaban tied to lower VTE risk in ambulatory cancer patients

Predictors of psychological resilience in NSCLC patients after surgery

Predictors of psychological resilience in NSCLC patients after surgery

A new tool can predict Asian women's breast cancer risk and help them decide on a screening programme most suited for them.

A new tool can predict Asian women's breast cancer risk and help them decide on a screening programme most suited for them.